AGC Biologics today announced Whitney Sandberg has been appointed as the company’s Vice President for Quality in Colorado. In this position she will have executive oversight for quality operations at the company’s two facilities in the state, located in Boulder and Longmont. Both facilities provide AGC Biologics critical resources for serving its global clientele, and Sandberg’s expertise will ensure each location produces products of the highest quality that meet global GMP requirements and industry expectations.
“We are excited to bring Whitney on board to lead our Quality teams in the state of Colorado, one of the most important parts of our growing global network of facilities,” said Paul Tsang, Executive Vice President, Global Quality for AGC Biologics. “She brings a wide range of experience and excellent leadership skills, and I am confident that Whitney will lead our Quality teams to great success, and play a pivotal role in helping our Boulder and Longmont facilities become cornerstones in the Colorado biotechnology industry.”
Sandberg brings more than 20 years of experience to the role, and her expertise spans quality assurance operations and quality systems, and integration and quality management for the manufacturing of biopharmaceuticals, pharmaceuticals and radiopharmaceuticals. Most recently, she served as Sr. Director of the Global Quality Biologics Business Unit at Patheon Biologics.
Sandberg has held positions of increasing responsibilities at Wyeth BioPharma, Akorn Pharmaceuticals, KV Pharmaceuticals, Mallinckrodt, Bristol Myers-Squibb and Thermo Fisher Scientific (Patheon Biologics). She holds a Bachelor of Arts in chemistry from Southern Illinois University.
